维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="VECSLER M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Combined genetic profiles of components and regulators of the vitamin K-dependent gamma- carboxylation system affect individual sensitivity to warfarin 显示文摘	Vecsler M Loebstein R Almog S	2006	Thromb Haemost2006，95，2：	1
2	Combined genetic profiles of components and regulators of the vitamin K - dependent gamma - carboxylation system affect individual sensitivity to warfarih 显示文摘	Vecsler M Loebstein R Almog S	2006	Thromb Haemost2006，95，：	1
3	Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9显示文摘	Loebstein R Vecsler M Kurnik D	2005	Clin Pharmacol Ther2005，77，5：	1
4	Combined genetic profiles of components and regulators of the vitamin K - deperdent gamma - carboxylation system affect individual sensitivity to warfarin 显示文摘	Vecsler M Loebstein R Almog S	2006	Thromb Haemost2006，95，：	1
5	Combined genetic profiles of components and regulators of the vitamin K-dependent gammacarboxylation system affect individual sensitivity to warfarin 显示文摘	Vecsler M Loebstein R Almog S	2006	Thromb Haemost2006，95，2：	1
6	A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance 显示文摘	Loebstein R Dvoskin I Halkin H Vecsler M Lubetsky A Rechavi G	2007	Blood2007，109，6：	1
7	Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9显示文摘	Loebstein R Vecsler M Kurnik D Austerweil N Gak E Halkin H	2005	Clin Pharmacol Ther2005，77，：	1
8	Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin 显示文摘	Vecsler M Loebstein R Almog S	2006	Thromb Haemost2006，95，2：	1
9	Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin显示文摘	Loebstein R Almog S	2006	Thromb Haemost2006，95，2：	1
10	Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P4502C9显示文摘	Vecsler M Kurnik D	2005	Clin Pharmacol Ther2005，77，5：	1
11	Common genetic variants of microsomal epoxide hydrolase af- fect warfarin dose requirements beyond the effect of eytoehrome P450 2C9 显示文摘	Loebstein R Vecsler M Kurnik D	2005	Clin Pharamacol Ther2005，77，5：	1
12	Common genetic variants of mierosomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9 显示文摘	Loebstein R Vecsler M Kumik D	2005	Clin Pharmacol Ther2005，77，5：	1
13	Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin 显示文摘	Vecsler M Loebstein R Almog S Kumik D Goldman B Halkin H	2006	Thromb Haemost2006，95，2：	1
14	Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9显示文摘	Loebstein R Vecsler M Kurnik D Austerweil N Gak E Halkin H	2005	Clin Pharmacol Ther2005，77，5：	1
15	Combined ge- netic profiles of components and regulators of the vitamin K -dependent gamma-carboxylation system affect individual sensitivity to warfarin显示文摘	VECSLER M LOEBSTEIN R ALMOG S	2006	Thromb Haemost2006，95，2：	1
16	Epilepsy in Rett syndrome-the experience of a National Rett Center显示文摘	Nissenkorn A Gak E Vecsler M		0，，7：	1
17	Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin显示文摘	Vecsler M Loebstein R Almog S	2006	Thromb Haemost2006，95，2：	1
18	Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations显示文摘	Vecsler M Zeev B Nudelman L		0，，06：	1
19	Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9 显示文摘	Loebstein R Vecsler M Kurnik D	2005	Clin Pharmacol Ther2005，77，5：	1
20	Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations 显示文摘	Vecsler M Zeev B Nudelman L	2011	PLoS One2011，6，20：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示